Table 1.
Patient’s characteristics and operation details.
| Control group (n = 32) | Patch group (n = 31) | P value | |
|---|---|---|---|
| Age (years) | 52 (42–63) | 47 (40–61) | 0.527 |
| Height (cm) | 158 (153–163) | 159 (155–161) | 0.581 |
| Weight (kg) | 61.3 ± 10.8 | 58.1 ± 9.8 | 0.229 |
| BMI (kg/m2) | 24 (22–27) | 23 (21–25) | 0.284 |
| ASA physical status (1/2/3) | 18/13/1 | 19/12/0 | > 0.999 |
| Diagnosis | 0.743 | ||
| Adenomyomatosis or polyps | 9 (28%) | 12 (39%) | |
| Cholecystitis | |||
| Mild | 12 (38%) | 10 (32%) | |
| Moderate | 2 (6%) | 3 (10%) | |
| Severe | 9 (28%) | 6 (19%) | |
| Crystalloid (mL) | 300 (275–400) | 300 (275–400) | 0.916 |
| Bleeding (mL) | 10 (10–20) | 15 (5–20) | 0.938 |
| Total dose of remifentanil (μg) | 400 (320–600) | 350 (280–400) | 0.055 |
| Operation time (min) | 50 (40–65) | 50 (35–57.5) | 0.229 |
| Anesthesia time (min) | 85 (70–97.5) | 80 (65–90) | 0.348 |
Values are presented as mean ± standard deviation, median (interquartile range) or number (proportion).
BMI body mass index, ASA American Society of Anesthesiologists.